Vascular protection of salicin on IL-1β-induced endothelial inflammatory response and damages in retinal endothelial cells
Source abstract
Abstract
Retinal endothelial cells (RECs) are involved in many ocular diseases such as age-related macular degeneration (AMD) and diabetic retinopathy. Salicin is the major ingredient of willow bark extract, and it has been shown to be a potent anti-inflammatory agent. We aim to explore whether salicin has a vascular protective effect in RECs. Our data indicate that the presence of salicin in RECs culture media ameliorates interleukin-1β (IL-1β)-induced cellular reactive oxygen species (ROS) production and NADPH oxidase 4 (NOX-4) expression. At the cellular level, salicin attenuates IL-1β-induced mitochondrial injury as revealed by its preservation on mitochondrial membrane potential (MMP). Furthermore, salicin inhibits IL-1β-induced production of pro-inflammatory cytokines such as tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6), and monocyte chemoattractant protein-1 (MCP-1), vascular adhesion molecules such as intercellular cell adhesion molecule-1 (iCAM-1) and vascular cell adhesion molecule 1 (VCAM-1), and high-mobility group protein 1 (HMGB-1). On the other hand, salicin recovers IL-1β-induced reduction of endothelial nitric oxide synthase (eNOS) and nitric oxide (NO) release. The presence of salicin significantly reduces the IL-1β-induced release of lactate dehydrogenase (LDH), indicating that it mitigates cytokine caused cytotoxicity. Mechanistically, we show that salicin suppresses IL-1β-induced activation of the nuclear factor-kappa B (NF-κB) signaling as revealed by its suppression on nuclear p65 protein and transfected NF-κB promoter. Collectively, our study demonstrates by multiple facets of its mechanisms that salicin is a protective agent in retinal endothelial cells. These results imply its potential use in therapeutic usage of retinal disease.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Retinal Diseases and Treatments · Glaucoma and retinal disorders · Retinal Imaging and Analysis
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of ophthalmology, Weihai Central hospital
References (21)
Show source-provided references
1. 10.5301/EJO.2010.604910.5301/EJO.2010.6049 ↗
2. 10.1007/978-3-540-29542-6_810.1007/978-3-540-29542-6_8 ↗
3. 10.1016/S0140-6736(18)31550-210.1016/S0140-6736(18)31550-2 ↗
4. 10.1097/ICU.000000000000036210.1097/ICU.0000000000000362 ↗
5. Whitmore SS, Braun TA, Skeie JM, et al. Altered gene expression in dry age-related macular degeneration suggests early loss of choroidal endothelial cells. Mol Vis. 2013;19:2274–2297.
6. 10.17925/USOR.2017.10.02.11910.17925/USOR.2017.10.02.119 ↗
7. 10.3390/ijms1904094210.3390/ijms19040942 ↗
8. 10.1002/ptr.274710.1002/ptr.2747 ↗
9. 10.1016/S0009-9236(03)00116-410.1016/S0009-9236(03)00116-4 ↗
10. 10.1016/j.intimp.2015.04.01610.1016/j.intimp.2015.04.016 ↗
11. 10.1007/s00011-013-0685-110.1007/s00011-013-0685-1 ↗
12. 10.1080/21691401.2019.158028610.1080/21691401.2019.1580286 ↗
13. 10.1080/21691401.2019.159385710.1080/21691401.2019.1593857 ↗
14. 10.1007/s12192-016-0735-z10.1007/s12192-016-0735-z ↗
15. 10.1021/np500177u10.1021/np500177u ↗
16. 10.1016/j.phymed.2011.08.06510.1016/j.phymed.2011.08.065 ↗
17. 10.1055/s-0030-127072210.1055/s-0030-1270722 ↗
18. 10.1002/ptr.512610.1002/ptr.5126 ↗
19. 10.1016/j.freeradbiomed.2012.12.00610.1016/j.freeradbiomed.2012.12.006 ↗
20. 10.1161/01.CIR.0000105680.92873.7010.1161/01.CIR.0000105680.92873.70 ↗
21. 10.2119/molmed.2014.0006310.2119/molmed.2014.00063 ↗